Edwards Lifesciences (EW) Capital Expenditures Growth (1y) (2010 - 2026)
Powered by 
Analysis
Edwards Lifesciences (EW) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.40 Bn | 175.80 Bn | 7.27 Bn | -1.00% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | -27.50% |
| 3 | Medtronic | 117.21 Bn | 108.39 Bn | 6.34 Bn | -0.20% |
| 4 | Stryker | 105.12 Bn | 101.64 Bn | 4.50 Bn | 10.38% |
| 5 | Boston Scientific | 64.52 Bn | 63.98 Bn | 3.85 Bn | 24.20% |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.69 Bn | 1.35 Bn | 35.70% |
| 7 | Alcon | 33.09 Bn | 31.63 Bn | 1.68 Bn | 5.88% |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn | -9.99% |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | -6.52% |
| 10 | Zimmer Biomet Holdings | 17.78 Bn | 17.37 Bn | 1.54 Bn | 8.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.70% |
| Mar 31, 2026 | 15.89% |
| Dec 31, 2025 | 95.58% |
| Sep 30, 2025 | 10.79% |
| Jun 30, 2025 | -42.27% |
| Mar 31, 2025 | -14.24% |
| Dec 31, 2024 | -43.60% |
| Sep 30, 2024 | -6.15% |
| Jun 30, 2024 | 78.29% |
| Mar 31, 2024 | 6.18% |
| Dec 31, 2023 | 28.16% |
| Sep 30, 2023 | -7.68% |
| Jun 30, 2023 | 11.14% |
| Mar 31, 2023 | -15.41% |
| Dec 31, 2022 | -23.27% |
| Sep 30, 2022 | -1.32% |
| Jun 30, 2022 | -37.81% |
| Mar 31, 2022 | -31.42% |
| Dec 31, 2021 | -20.67% |
| Sep 30, 2021 | -41.24% |